Krka

We are one of the leading international generic pharmaceutical companies in the world, present in more than 70 countries. We have developed a global business network, which in addition to our production plants in Slovenia, comprises production and distribution centres in the Russian Federation, Poland, Croatia, and Germany.
 
We are the market leader in Slovenia, but our presence on the generic pharmaceutical markets of eastern, central and south-eastern Europe and the markets of western Europe is also significant. We are strengthening presence in the countries of the Middle East, the Far East, Africa, and the Americas. The Krka Group generates over 1.5 billion euros by sales of products and services per year. This places us among the leading generic pharmaceutical companies.
 
Our advanced pharmaceutical production and the vertically integrated business model allow us to provide customers with a wide range of safe, high-quality and effective prescription pharmaceuticals, non-prescription products, and animal health products. Krka's portfolio primarily consists of solid dosage forms. Health resort and tourist services of Terme Krka round off our product range.
 
We focus on generic prescription pharmaceuticals marketed under Krka’s brands. In order to increase the competitive advantage of our product portfolio, we allocate a large portion of revenue to research and development. We have more than 170 new products in the pipeline. Our main therapeutic categories include pharmaceuticals for the cardiovascular system, central nervous system, gastrointestinal tract, and pain relief. Of other therapeutic areas, we focus on diabetes, antiaggregant therapy, oncology, and urology. We are also entering new therapeutic areas and expanding our portfolios of non-prescription products and animal health products, especially for companion animals.
 
We have been expanding our marketing-and-sales network and increasing market shares through establishment of our own companies and mergers on target markets. Our objective is to strengthen the Krka Group’s market position in Europe and Central Asian markets and enter new high-potential markets.